[Clinical evaluation of Mexase].
D000328:Adult; D000368:Aged; D000681:Amylases / Q000097:blood / Q000652:urine; D001963:Bromelains / Q000627:therapeutic use*; D007464:Clioquinol / Q000627:therapeutic use*; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008049:Lipase / Q000097:blood; D008297:Male; D008875:Middle Aged; D010194:Pancreatin / Q000627:therapeutic use*; D010618:Phenanthrolines / Q000627:therapeutic use*; D013997:Time Factors
D010618:Phenanthrolines; D007464:Clioquinol; D010194:Pancreatin; D001963:Bromelains; D008049:Lipase; D000681:Amylases
Ocena kliniczna preparatu "meksaza".